Workshop

Advanced EUDRAGIT® Workshop

November 19, 2024​ | Cambridge, MA, USA


Overview

This workshop will be an excellent opportunity for technical staff in the pharmaceutical industry to learn about the use of EUDRAGIT® polymers in modified release formulations, oral delivery of peptide drugs, spray drying techniques, and hot melt extrusion approaches for advanced drug delivery.


Key learnings for participants

  • EUDRATEC® technologies for custom release profiles​
  • Optimizing your immediate, sustained, or modified release profiles​
  • Troubleshooting hot melt extrusion, spray drying, and other coating processes​
  • Increasing solubility enhancement ​
  • Using amorphous solid dispersions




Note: Please fill in your details and click 'Submit' to register for the workshop. Once we have received your registration, we will send you a status notification as soon as possible. Due to the high demand for our workshops, we sometimes need to reject registrations or put you on a waiting list. Workshop materials will be available for download at the end of the workshop. Any photographs taken during the event are the property of Evonik and may be used for promotional purposes.


Details
Participation fee: $50
Workshop language: English



Agenda
The workshop will start at 08:30 a.m. on Tuesday, November 19, 2024, and finish at 4:00 p.m. on the same day. To see the detailed workshop program please click here.



Venue
The workshop will take place at:
Evonik Cambridge Innovation Satellite
238 Massachusetts Ave
Cambridge, MA 02139, USA
6th Floor Event Space

Fill out the form to register for the workshop:

Agenda

08:30 a.m. | Registration & Breakfast

09:15 a.m. | Welcome & Introduction

09:30 a.m. | EUDRAGIT® and Customized Release With EUDRATEC® Technologies
Brian Phillips
MS – Principal Scientist, FAS
Evonik Health Care

10:30 a.m. | Coffee Break & Networking

10:45 a.m. | Particles for Humanity
Dr. Ana Jaklenec
Principal research scientist and principal investigator
MIT

11:15 a.m. | Solubility Enhancement of Poorly Soluble Drugs Using EUDRAGIT® Polymeric Excipient in Amorphous Solid Dispersion Technology
Dr. Irfan Syed
Associate Director, FAS
Evonik Health Care

12:00 p.m. | Lunch & Networking

01:00 p.m. | Personification of Amorphous Solid Dispersions by EUDRATEC® Soluflow Technology
Dr. Manish Rane
Associate Director, Technical Sales, NA
Evonik Health Care

01:30 p.m. | EUDRACAP® Ready-to-Fill Capsules for Enhanced Functional Performance and targeted drug delivery
Dr. Kamlesh Oza
Head of Technical Sales NA, Formulation & Application Services
Evonik Health Care

02:00 p.m. | To Be Announced

02:30 p.m. | Coffee Break & Networking

02:45 p.m. | Customizing Drug Release Profiles with EUDRAGIT® Polymeric Systems
Dr. Nicole Mendonsa
Principal Scientist, FAS
Evonik Health Care

03:15 p.m. | Panel Q&A and Troubleshooting

04:00 p.m. Wrap-up



​
Disclaimer
Notice for business transactions
We assume that you are not currently or foreseeably involved in a business decision in favour of or in direct connection with the Evonik Group or, if this is the case, the decision will not be influenced by this invitation. Therefore, we do not see any concerns on our part regarding your participation. However, we would like to ask you to ensure that you are allowed to accept the invitation in accordance with the regulations that apply to you.

Note for public officials
We assume that you are not or have not been involved in any official act in favour of or in connection with the Evonik Group, either now or in the foreseeable future or in the past and therefore your participation in the event is not subject to any concerns. In addition, we ask you to ensure that your superior approves your participation or you may also accept the invitation in accordance with the rules applicable to you. By registering or participating, you confirm to us that the acceptance of this invitation is permitted according to your internal rules and that you have obtained all necessary approvals. If this is not the case, we ask you for a corresponding note.

Tax notices
Any tax liability resulting from this event will be borne by Evonik Industries AG through a flat-rate tax levy pursuant to Section 37b of the German Income Tax Act (EStG). If you are not taxable in Germany, please clarify whether you must report the invitation to your employer for taxation or whether taxation must be made via your income tax return.



QUESTIONS? 

Emily Peters
Regional Marketing Manager, North America
Phone: +1 732 668-5892

Cléa Michel

Cléa Michel is product manager for Cell Culture Ingredients at Evonik Health Care. She provides biopharma companies and media manufacturers with the finest specialty ingredients to increase cell culture performance. Cléa has a background in biochemistry and biotechnology engineering and holds a master’s degree from the National Institute of Applied Sciences in Lyon, France. She has held various positions in marketing, project management and business development and is passionate about innovative solutions that enable the successful development of life-saving biopharmaceuticals.
Dr. Stephan Brinkmann

Stephan Brinkmann works as project manager and head of Evonik's Biopharma Applications group at Evonik R&D for the Health Care business line. He is responsible for biopharma innovation projects as well as application tests of Evonik's cell culture ingredients (i.e., cQrex® peptides). Stephan studied molecular biotechnology at Bielefeld University in Germany, where he specialized in biopharma upstream and downstream process development. Before joining Evonik, Stephan worked in Switzerland on industrial mammalian cell line development for the production of therapeutic biologics. Stephan obtained his Ph.D. in a public private partnership with Sanofi and later Evotec at Fraunhofer IME in Giessen with a focus on the discovery of natural products, especially peptides.